Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04872257Completed
Randomised, triple-blind trial in Vitiligo comparing Oral Vitamin D + NB-UVB with Placebo + NB-UVB (2 arms). Primary endpoint: Vitiligo Area and Severity Index at Week 24. Started Sep 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04872257.